{
  "question_stem": {
    "en": "A 57-year-old man comes to the emergency department due to fevers and painful mouth ulcers. He recently began methotrexate therapy for psoriasis. However, the patient has mistakenly taken the medication daily instead of 3 times a week. His past medical history is also significant for hypertension and chronic kidney disease. Temperature is 38.1 C (100.6 F). Examination reveals multiple aphthous ulcers in the oral pharynx. A complete blood count is as follows:\n\nHemoglobin 10.4 g/dL\nPlatelets 120,000/mm³\nLeukocytes 2,800/mm³",
    "zh": "一名57岁男性因发热和口腔溃疡疼痛就诊于急诊科。他最近开始接受甲氨蝶呤治疗银屑病。然而，患者误将该药物每日服用，而不是每周服用3次。他的既往病史还包括高血压和慢性肾病。体温38.1°C (100.6°F)。检查显示口咽部有多个口疮性溃疡。全血细胞计数如下：\n\n血红蛋白10.4 g/dL\n血小板120,000/mm³\n白细胞2,800/mm³"
  },
  "question": {
    "en": "Which of the following is the best next step in management?",
    "zh": "以下哪项是最佳的下一步处理措施？"
  },
  "options": {
    "A": {
      "en": "Allopurinol",
      "zh": "别嘌醇"
    },
    "B": {
      "en": "Amifostine",
      "zh": "氨磷汀"
    },
    "C": {
      "en": "Dexrazoxane",
      "zh": "地拉罗司"
    },
    "D": {
      "en": "Filgrastim",
      "zh": "非格司亭"
    },
    "E": {
      "en": "Folinic acid",
      "zh": "亚叶酸"
    },
    "F": {
      "en": "Mesna",
      "zh": "美司钠"
    },
    "G": {
      "en": "Ondansetron",
      "zh": "昂丹司琼"
    }
  },
  "correct_answer": "E",
  "explanation": {
    "en": "The patient is presenting with symptoms consistent with methotrexate toxicity due to an overdose. Methotrexate (MTX) is a folic acid antagonist that inhibits dihydrofolate reductase (DHFR), an enzyme critical for DNA synthesis. This inhibition leads to cell death, particularly in rapidly dividing cells like those in the gastrointestinal mucosa and bone marrow. The patient's mouth ulcers (aphthous ulcers) are a manifestation of gastrointestinal mucositis, and his leukopenia (low white blood cell count) indicates bone marrow suppression. The correct management for MTX toxicity is the administration of folinic acid (leucovorin). Folinic acid is a reduced form of folic acid that bypasses the DHFR enzyme, allowing for the synthesis of purines and thymidylate, thereby rescuing non-cancerous cells from MTX's cytotoxic effects. It is most effective when administered early after MTX exposure.\n\n(Choice A) Allopurinol is a xanthine oxidase inhibitor used for gout and tumor lysis syndrome prevention. It does not counteract methotrexate toxicity.\n(Choice B) Amifostine is a cytoprotective agent used to reduce nephrotoxicity and xerostomia associated with certain chemotherapies, but not methotrexate.\n(Choice C) Dexrazoxane is an iron-chelating agent used to prevent anthracycline-induced cardiotoxicity.\n(Choice D) Filgrastim is a granulocyte colony-stimulating factor that stimulates neutrophil production. While the patient is leukopenic, the primary issue is the underlying methotrexate toxicity, and direct stimulation of granulocytes without addressing the root cause is not the best initial step. Folinic acid will help restore bone marrow function.\n(Choice F) Mesna is used to prevent hemorrhagic cystitis caused by cyclophosphamide or ifosfamide.\n(Choice G) Ondansetron is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting, which is not the primary presenting symptom or the most critical management issue here.",
    "zh": "患者出现的症状与甲氨蝶呤过量引起的毒性一致。甲氨蝶呤 (MTX) 是一种叶酸拮抗剂，可抑制二氢叶酸还原酶 (DHFR)，该酶对DNA合成至关重要。这种抑制作用导致细胞死亡，尤其是在快速分裂的细胞中，如胃肠道粘膜和骨髓细胞。患者的口腔溃疡（口疮性溃疡）是胃肠粘膜炎的表现，其白细胞减少症（白细胞计数低）表明骨髓抑制。甲氨蝶呤毒性的正确处理方法是给予亚叶酸（甲酰四氢叶酸钙）。亚叶酸是叶酸的还原形式，可绕过DHFR酶，从而允许合成嘌呤和胸苷酸，从而将非癌细胞从MTX的细胞毒性作用中解救出来。它在MTX暴露后早期给药时最有效。\n\n(选项 A) 别嘌醇是一种黄嘌呤氧化酶抑制剂，用于治疗痛风和肿瘤溶解综合征的预防。它不能对抗甲氨蝶呤的毒性。\n(选项 B) 氨磷汀是一种细胞保护剂，用于减轻与某些化疗相关的肾毒性和口干症，但不能减轻甲氨蝶呤的毒性。\n(选项 C) 地拉罗司是一种铁螯合剂，用于预防蒽环类药物引起的心脏毒性。\n(选项 D) 非格司亭是一种粒细胞集落刺激因子，可刺激中性粒细胞的生成。虽然患者出现白细胞减少症，但主要问题是潜在的甲氨蝶呤毒性，在没有解决根本原因的情况下直接刺激粒细胞并不是最好的初始步骤。亚叶酸将有助于恢复骨髓功能。\n(选项 F) 美司钠用于预防环磷酰胺或异环磷酰胺引起的出血性膀胱炎。\n(选项 G) 昂丹司琼是一种5-HT3受体拮抗剂，用于治疗恶心和呕吐，这不是主要的表现症状，也不是这里最关键的处理问题。"
  },
  "summary": {
    "en": "This question tests the understanding of methotrexate toxicity and its management. It assesses the ability to recognize the clinical signs and laboratory findings indicative of methotrexate overdose and to identify the appropriate antidote.\n\nTo solve this question, one must first identify the patient's symptoms and laboratory results as consistent with methotrexate toxicity. Then, recall the mechanism of action of methotrexate and its antidote, folinic acid (leucovorin), and differentiate it from other supportive or unrelated medications.",
    "zh": "本题考察对甲氨蝶呤毒性及其处理的理解。它评估识别甲氨蝶呤过量的临床体征和实验室结果并确定适当解毒剂的能力。\n\n要解决这个问题，首先必须确定患者的症状和实验室结果与甲氨蝶呤毒性一致。然后，回忆甲氨蝶呤及其解毒剂亚叶酸（甲酰四氢叶酸钙）的作用机制，并将其与其他支持性或无关药物区分开来。"
  },
  "tags": "Methotrexate toxicity; Folic acid antagonist; Dihydrofolate reductase inhibitor; Mucositis; Leukopenia; Folinic acid; Leucovorin; Antidote; Chemotherapy side effects; Pharmacology",
  "category": "Pharma",
  "question_id": "1818",
  "has_exhibits": true,
  "exhibit_count": 1,
  "exhibit_files": [
    "image1.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Pharma 23\\1818",
  "extracted_at": "2025-11-05T19:45:19.184537",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 2,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:47:26.135485",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}